BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37150906)

  • 21. Persistence of the Probiotic
    Mahalak KK; Firrman J; Bobokalonov J; Narrowe AB; Bittinger K; Daniel S; Tanes C; Mattei LM; Zeng WB; Soares JW; Kobori M; Lemons JMS; Tomasula PM; Liu L
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia.
    Khailova L; Baird CH; Rush AA; Barnes C; Wischmeyer PE
    Clin Nutr; 2017 Dec; 36(6):1549-1557. PubMed ID: 27745813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live and pasteurized Akkermansia muciniphila ameliorates diabetic cognitive impairment by modulating gut microbiota and metabolites in db/db mice.
    Du Y; An Y; Song Y; Li N; Zheng J; Lu Y
    Exp Neurol; 2024 Aug; 378():114823. PubMed ID: 38782351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotic Lactobacillus rhamnosus GG reduces mortality of septic mice by modulating gut microbiota composition and metabolic profiles.
    Chen L; Li H; Chen Y; Yang Y
    Nutrition; 2020 Oct; 78():110863. PubMed ID: 32593948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of Akkermansia muciniphila with host-derived substances, bacteria and diets.
    Hagi T; Belzer C
    Appl Microbiol Biotechnol; 2021 Jun; 105(12):4833-4841. PubMed ID: 34125276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactobacillus rhamnosus GG modifies the metabolome of pathobionts in gnotobiotic mice.
    Kim J; Balasubramanian I; Bandyopadhyay S; Nadler I; Singh R; Harlan D; Bumber A; He Y; Kerkhof LJ; Gao N; Su X; Ferraris RP
    BMC Microbiol; 2021 Jun; 21(1):165. PubMed ID: 34082713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of ethanol-induced
    Grander C; Adolph TE; Wieser V; Lowe P; Wrzosek L; Gyongyosi B; Ward DV; Grabherr F; Gerner RR; Pfister A; Enrich B; Ciocan D; Macheiner S; Mayr L; Drach M; Moser P; Moschen AR; Perlemuter G; Szabo G; Cassard AM; Tilg H
    Gut; 2018 May; 67(5):891-901. PubMed ID: 28550049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oral Akkermansia muciniphila supplementation in healthy dogs following antimicrobial administration.
    Jugan MC; Rudinsky AJ; Gordon A; Kramer DL; Daniels JB; Paliy O; Boyaka P; Gilor C
    Am J Vet Res; 2018 Aug; 79(8):884-892. PubMed ID: 30058857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure-the current facts and evidence.
    Lakshmanan AP; Murugesan S; Al Khodor S; Terranegra A
    J Transl Med; 2022 Sep; 20(1):430. PubMed ID: 36153618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akkermansia muciniphila: a promising target for the therapy of metabolic syndrome and related diseases.
    Zhou JC; Zhang XW
    Chin J Nat Med; 2019 Nov; 17(11):835-841. PubMed ID: 31831130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation.
    Wu D; Zhang C; Liu Y; Yao J; Yang X; Wu S; Du J; Yang X
    J Microbiol Immunol Infect; 2023 Oct; 56(5):893-908. PubMed ID: 36890066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution and competitive strategies of
    Kim JS; Kang SW; Lee JH; Park SH; Lee JS
    Gut Microbes; 2022; 14(1):2025017. PubMed ID: 35263215
    [No Abstract]   [Full Text] [Related]  

  • 34.
    Higarza SG; Arboleya S; Arias JL; Gueimonde M; Arias N
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33678110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites.
    Ding Y; Bu F; Chen T; Shi G; Yuan X; Feng Z; Duan Z; Wang R; Zhang S; Wang Q; Zhou J; Chen Y
    Appl Microbiol Biotechnol; 2021 Nov; 105(21-22):8411-8426. PubMed ID: 34617139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucin degrader
    Kim S; Shin YC; Kim TY; Kim Y; Lee YS; Lee SH; Kim MN; O E; Kim KS; Kweon MN
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33678130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A next generation probiotic,
    Zhai Q; Feng S; Arjan N; Chen W
    Crit Rev Food Sci Nutr; 2019; 59(19):3227-3236. PubMed ID: 30373382
    [No Abstract]   [Full Text] [Related]  

  • 38. Pasteurized
    Lawenius L; Scheffler JM; Gustafsson KL; Henning P; Nilsson KH; Colldén H; Islander U; Plovier H; Cani PD; de Vos WM; Ohlsson C; Sjögren K
    Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E480-E491. PubMed ID: 31961709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactobacillus rhamnosus GG colonization in early life regulates gut-brain axis and relieves anxiety-like behavior in adulthood.
    Zhou B; Jin G; Pang X; Mo Q; Bao J; Liu T; Wu J; Xie R; Liu X; Liu J; Yang H; Xu X; Wang B; Cao H
    Pharmacol Res; 2022 Mar; 177():106090. PubMed ID: 35065201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early-life high-fat diet-induced obesity programs hippocampal development and cognitive functions via regulation of gut commensal Akkermansia muciniphila.
    Yang Y; Zhong Z; Wang B; Xia X; Yao W; Huang L; Wang Y; Ding W
    Neuropsychopharmacology; 2019 Nov; 44(12):2054-2064. PubMed ID: 31207607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.